120 related articles for article (PubMed ID: 8516662)
1. Discovery and development of antipicornaviral agents.
McKinlay MA
Scand J Infect Dis Suppl; 1993; 88():109-15. PubMed ID: 8516662
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibitors of picornavirus replication.
De Palma AM; Vliegen I; De Clercq E; Neyts J
Med Res Rev; 2008 Nov; 28(6):823-84. PubMed ID: 18381747
[TBL] [Abstract][Full Text] [Related]
3. Combating enterovirus replication: state-of-the-art on antiviral research.
Thibaut HJ; De Palma AM; Neyts J
Biochem Pharmacol; 2012 Jan; 83(2):185-92. PubMed ID: 21889497
[TBL] [Abstract][Full Text] [Related]
4. Picornavirus inhibitors.
Carrasco L
Pharmacol Ther; 1994; 64(2):215-90. PubMed ID: 7533301
[TBL] [Abstract][Full Text] [Related]
5. Chiral discrimination and antipicornavirus activity of 6-oxazolinylisoflavan.
Quaglia MG; Desideri N; Bossù E; Sestili I; Tomao P; Conti C; Orsi N
Chirality; 1993; 5(5):356-8. PubMed ID: 8398593
[TBL] [Abstract][Full Text] [Related]
6. Imidazo[1,2-b]pyridazines, novel nucleus with potent and broad spectrum activity against human picornaviruses: design, synthesis, and biological evaluation.
Hamdouchi C; Sanchez-Martinez C; Gruber J; Del Prado M; Lopez J; Rubio A; Heinz BA
J Med Chem; 2003 Sep; 46(20):4333-41. PubMed ID: 13678411
[TBL] [Abstract][Full Text] [Related]
7. [Pleconaril, a new aniviral drug with activity against picornavirus].
Reina J; Ballesteros F
Rev Esp Quimioter; 2000 Sep; 13(3):257-62. PubMed ID: 11086273
[No Abstract] [Full Text] [Related]
8. A structurally biased combinatorial approach for discovering new anti-picornaviral compounds.
Tsang SK; Cheh J; Isaacs L; Joseph-McCarthy D; Choi SK; Pevear DC; Whitesides GM; Hogle JM
Chem Biol; 2001 Jan; 8(1):33-45. PubMed ID: 11182317
[TBL] [Abstract][Full Text] [Related]
9. Coxsackievirus-induced myocarditis: new trends in treatment.
Liu Z; Yuan J; Yanagawa B; Qiu D; McManus BM; Yang D
Expert Rev Anti Infect Ther; 2005 Aug; 3(4):641-50. PubMed ID: 16107202
[TBL] [Abstract][Full Text] [Related]
10. Treatment of picornavirus infections.
Rotbart HA
Antiviral Res; 2002 Feb; 53(2):83-98. PubMed ID: 11750935
[TBL] [Abstract][Full Text] [Related]
11. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
12. Application of crystallography to the design of antiviral agents.
Rossmann MG; McKinlay MA
Infect Agents Dis; 1992 Feb; 1(1):3-10. PubMed ID: 1365526
[TBL] [Abstract][Full Text] [Related]
13. [In vitro effectiveness of new antiviral substances. 1. Results of screening studies against selected picornaviruses].
Tonew M; Tonew E
Virologie; 1985; 36(2):103-9. PubMed ID: 2994288
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activity and molecular features of benzimidazoles.
O'Sullivan DG; Ludlow C; Pantic D; Wallis AK
Antimicrob Agents Chemother (Bethesda); 1969; 9():153-9. PubMed ID: 4319306
[No Abstract] [Full Text] [Related]
15. Antiviral agents against picornaviruses.
Eggers HJ
Antiviral Res; 1985; Suppl 1():57-65. PubMed ID: 3002267
[No Abstract] [Full Text] [Related]
16. Design, synthesis and biological evaluation of antipicornaviral pyrrole-containing peptidomimetics.
Minchev I; Vladimirova S; Vezenkova L; Bijeva A; Moussis V; Nikolaeva-Glomb L; Tsikaris V; Czeuz M; Galabov A
Protein Pept Lett; 2007; 14(9):917-22. PubMed ID: 18045234
[TBL] [Abstract][Full Text] [Related]
17. Pleconaril Sanofi Synthélabo/ViroPharma.
Billich A
Curr Opin Investig Drugs; 2000 Nov; 1(3):303-7. PubMed ID: 11249712
[TBL] [Abstract][Full Text] [Related]
18. Virucidal hand treatments for prevention of rhinovirus infection.
Turner RB; Hendley JO
J Antimicrob Chemother; 2005 Nov; 56(5):805-7. PubMed ID: 16159927
[TBL] [Abstract][Full Text] [Related]
19. Association of respiratory picornaviruses with acute bronchiolitis in French infants.
Jacques J; Bouscambert-Duchamp M; Moret H; Carquin J; Brodard V; Lina B; Motte J; Andréoletti L
J Clin Virol; 2006 Apr; 35(4):463-6. PubMed ID: 16406692
[TBL] [Abstract][Full Text] [Related]
20. Treatment of the picornavirus common cold by inhibitors of viral uncoating and attachment.
McKinlay MA; Pevear DC; Rossmann MG
Annu Rev Microbiol; 1992; 46():635-54. PubMed ID: 1332585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
